BACKGROUND OF THE EWG The Expert Working Group (EWG) on Biomarkers of Drug-
Induced Cardiac Toxicity was established as a factfinding working group to the Nonclinical …

We have analyzed by different immunological methods the proteolytic degradation of
cardiac troponin I (cTnI) in human necrotic tissue and in serum. cTnI is susceptible to …

It has been shown that certain patients with cirrhosis have asymptomatic cardiac
abnormalities that have not yet been explained. Thus, cardiac troponin I, a specific marker of …

Two patients were investigated for unexplained increases in troponin T. In the first patient,
who had rhabdomyolysis and acute renal failure, troponin T reached a peak value of 13.50 …

We evaluated the ACCESS® cardiac troponin I (cTnI) immunoassay as a marker for
myocardial infarction (MI). Total imprecision was 6.0% to 13.5%, the minimum detectable …

The importance of determining the time since death is crucial to criminal, civil and forensic
cases. A technique exploiting the degradation of a protein, cardiac Troponin I (cTnI), to …

Objective: The diagnosis of perioperative myocardial infarction (PMI) after cardiac surgery
remains an important issue. The present study was designed to determine the relevance of …

This study aimed at evaluation of melatonin and some of its novel synthesized derivatives 3,
4, 9 and 10b as cardioprotective agents against doxorubicin-induced acute cardiac toxicity …

In patients with chest pain at rest but no ST‐segment elevation on the electrocardiogram, the
diagnoses of unstable angina and non‐Q‐wave myocardial infarction (MI) are usually …

We evaluated whether recent cocaine use alters the specificity of CK-MB, myoglobin, and
cardiac troponin I for acute myocardial infarction (AMI) in patients who are seen in the …